Covered recipient · General Payments record

RAVI PANDEY

Allopathic & Osteopathic Physicians Internal Medicine

NPI: 1881675452
CMS profile: 130349
Location: PALM BEACH GARDENS, FL

General Payments · PY2018–2024

$14,082.14

Reported across 342 records
CMS publication 2026-01-23

Latest program year · PY2024

$2,556.54

52 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated

The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

Nature of payment	Amount	Records
Food and Beverage	$2,556.54	52

By paying entity

PY2024 · sorted by reported total

Paying entity	Amount	Records
Acerta Pharma LLC	$857.42	10
Lilly USA, LLC	$235.07	7
Janssen Pharmaceuticals, Inc	$234.65	2
Edwards Lifesciences Corporation	$187.10	2
E.R. Squibb & Sons, L.L.C.	$138.11	3
Abbott Laboratories	$137.30	2
Boehringer Ingelheim Pharmaceuticals, Inc.	$114.03	1
Amgen Inc.	$109.40	1
PFIZER INC.	$107.50	5
Bayer HealthCare Pharmaceuticals Inc.	$77.28	3
Novo Nordisk AS	$76.78	4
Salix Pharmaceuticals, a division of Bausch Health US, LLC	$72.12	4
NOVARTIS PHARMACEUTICALS CORPORATION	$51.20	2
GlaxoSmithKline, LLC.	$48.59	2
Exact Sciences Corporation	$43.45	2
Reprise Biomedical, Inc.	$40.66	1
Analog Devices Inc.	$25.88	1

By program year

All program years on this page · sorted by year

Program year	Amount	Records
PY2018	$3,321.74	74
PY2019	$724.79	6
PY2020	$444.22	6
PY2021	$2,045.19	67
PY2022	$2,262.63	60
PY2023	$2,727.03	77
PY2024	$2,556.54	52

Payment records · PY2024 (52)

Sorted by paying entity, then date · as published by CMS

Program year 2024 2018 2019 2020 2021 2022 2023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.

Paying entity	Amount	Date	Nature of payment	Dispute status	Published	Record ID	Source
Abbott Laboratories	$115.37	07/16/2024	Food and Beverage	Undisputed	01/23/2026	1125319811	CMS
Abbott Laboratories	$21.93	12/04/2024	Food and Beverage	Undisputed	01/23/2026	1125319813	CMS
Amgen Inc.	$109.40	09/24/2024	Food and Beverage	Undisputed	01/23/2026	1115990784	CMS
Analog Devices Inc.	$25.88	03/21/2024	Food and Beverage	Undisputed	01/23/2026	1148206708	CMS
AstraZeneca Pharmaceuticals LP	$133.28	01/20/2024	Food and Beverage	Undisputed	01/23/2026	1105435628	CMS
AstraZeneca Pharmaceuticals LP	$112.06	02/13/2024	Food and Beverage	Undisputed	01/23/2026	1104759590	CMS
AstraZeneca Pharmaceuticals LP	$121.84	02/22/2024	Food and Beverage	Undisputed	01/23/2026	1105830333	CMS
AstraZeneca Pharmaceuticals LP	$122.30	04/17/2024	Food and Beverage	Undisputed	01/23/2026	1105704412	CMS
AstraZeneca Pharmaceuticals LP	$116.67	04/24/2024	Food and Beverage	Undisputed	01/23/2026	1105302834	CMS
AstraZeneca Pharmaceuticals LP	$110.82	08/15/2024	Food and Beverage	Undisputed	01/23/2026	1105685707	CMS
AstraZeneca Pharmaceuticals LP	$20.52	10/24/2024	Food and Beverage	Undisputed	01/23/2026	1104452990	CMS
AstraZeneca Pharmaceuticals LP	$13.34	11/09/2024	Food and Beverage	Undisputed	01/23/2026	1105495245	CMS
AstraZeneca Pharmaceuticals LP	$91.68	12/11/2024	Food and Beverage	Undisputed	01/23/2026	1105522567	CMS
AstraZeneca Pharmaceuticals LP	$14.91	12/21/2024	Food and Beverage	Undisputed	01/23/2026	1105899858	CMS
Bayer Healthcare Pharmaceuticals Inc.	$15.55	01/05/2024	Food and Beverage	Undisputed	01/23/2026	1086164976	CMS
Bayer Healthcare Pharmaceuticals Inc.	$31.38	04/02/2024	Food and Beverage	Undisputed	01/23/2026	1086129366	CMS
Bayer Healthcare Pharmaceuticals Inc.	$30.35	07/30/2024	Food and Beverage	Undisputed	01/23/2026	1086190978	CMS
Boehringer Ingelheim Pharmaceuticals, Inc.	$114.03	02/21/2024	Food and Beverage	Undisputed	01/23/2026	1118211720	CMS
E.R. Squibb & Sons, L.L.C.	$2.18	08/28/2024	Food and Beverage	Undisputed	01/23/2026	1101283568	CMS
E.R. Squibb & Sons, L.L.C.	$10.92	09/30/2024	Food and Beverage	Undisputed	01/23/2026	1101283572	CMS
E.R. Squibb & Sons, L.L.C.	$125.01	10/24/2024	Food and Beverage	Undisputed	01/23/2026	1101283582	CMS
Edwards Lifesciences Corporation	$59.89	03/05/2024	Food and Beverage	Undisputed	01/23/2026	1138821354	CMS
Edwards Lifesciences Corporation	$127.21	04/05/2024	Food and Beverage	Undisputed	01/23/2026	1138821364	CMS
Exact Sciences Corporation	$16.95	03/19/2024	Food and Beverage	Undisputed	01/23/2026	1114821557	CMS
Exact Sciences Corporation	$26.50	10/29/2024	Food and Beverage	Undisputed	01/23/2026	1114821563	CMS
GlaxoSmithKline, LLC.	$25.10	04/19/2024	Food and Beverage	Undisputed	01/23/2026	1116694387	CMS
GlaxoSmithKline, LLC.	$23.49	06/18/2024	Food and Beverage	Undisputed	01/23/2026	1116665969	CMS
Janssen Pharmaceuticals, Inc	$110.17	02/15/2024	Food and Beverage	Undisputed	01/23/2026	1077973790	CMS
Janssen Pharmaceuticals, Inc	$124.48	08/21/2024	Food and Beverage	Undisputed	01/23/2026	1077973758	CMS
Lilly USA, LLC	$21.86	01/20/2024	Food and Beverage	Undisputed	01/23/2026	1135370918	CMS
Lilly USA, LLC	$121.84	01/25/2024	Food and Beverage	Undisputed	01/23/2026	1135360188	CMS
Lilly USA, LLC	$18.68	03/29/2024	Food and Beverage	Undisputed	01/23/2026	1135329810	CMS
Lilly USA, LLC	$21.56	04/16/2024	Food and Beverage	Undisputed	01/23/2026	1135360190	CMS
Lilly USA, LLC	$12.43	06/25/2024	Food and Beverage	Undisputed	01/23/2026	1135362106	CMS
Lilly USA, LLC	$22.11	09/17/2024	Food and Beverage	Undisputed	01/23/2026	1135352465	CMS
Lilly USA, LLC	$16.59	10/25/2024	Food and Beverage	Undisputed	01/23/2026	1135332237	CMS
Novartis Pharmaceuticals Corporation	$28.08	02/02/2024	Food and Beverage	Undisputed	01/23/2026	1087286473	CMS
Novartis Pharmaceuticals Corporation	$23.12	10/29/2024	Food and Beverage	Undisputed	01/23/2026	1087286497	CMS
Novo Nordisk Inc	$22.86	01/11/2024	Food and Beverage	Undisputed	01/23/2026	1096931305	CMS
Novo Nordisk Inc	$16.67	03/15/2024	Food and Beverage	Undisputed	01/23/2026	1096682043	CMS
Novo Nordisk Inc	$14.39	06/07/2024	Food and Beverage	Undisputed	01/23/2026	1096781130	CMS
Novo Nordisk Inc	$22.86	07/13/2024	Food and Beverage	Undisputed	01/23/2026	1097528312	CMS
PFIZER INC.	$24.56	01/29/2024	Food and Beverage	Undisputed	01/23/2026	1131532227	CMS
PFIZER INC.	$17.34	02/13/2024	Food and Beverage	Undisputed	01/23/2026	1131535143	CMS
PFIZER INC.	$21.80	03/22/2024	Food and Beverage	Undisputed	01/23/2026	1131659452	CMS
PFIZER INC.	$19.97	06/17/2024	Food and Beverage	Undisputed	01/23/2026	1131616337	CMS
PFIZER INC.	$23.83	09/23/2024	Food and Beverage	Undisputed	01/23/2026	1131940507	CMS
Reprise Biomedical, Inc.	$40.66	10/01/2024	Food and Beverage	Undisputed	01/23/2026	1144663411	CMS
Salix Pharmaceuticals, a division of Bausch Health US, LLC	$22.34	02/07/2024	Food and Beverage	Undisputed	01/23/2026	1153636762	CMS
Salix Pharmaceuticals, a division of Bausch Health US, LLC	$15.33	05/07/2024	Food and Beverage	Undisputed	01/23/2026	1153487139	CMS
Salix Pharmaceuticals, a division of Bausch Health US, LLC	$17.04	05/13/2024	Food and Beverage	Undisputed	01/23/2026	1153614006	CMS
Salix Pharmaceuticals, a division of Bausch Health US, LLC	$17.41	07/10/2024	Food and Beverage	Undisputed	01/23/2026	1153697367	CMS

Source & provenance

Dataset: CMS Open Payments — General Payments
Publisher of source data: Centers for Medicare & Medicaid Services
CMS publication date: 2026-01-23
Program years on this page: 2018, 2019, 2020, 2021, 2022, 2023, 2024
Source files: Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.